| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 08/15/2006 | US7091232 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |
| 08/15/2006 | US7091213 Phosphorus-containing compounds and uses thereof |
| 08/15/2006 | US7091204 Sulfonamides |
| 08/15/2006 | US7091195 Derived from plants; for preventing or inhibiting tumor growth |
| 08/15/2006 | US7090871 Composition containing pyrrolizidine-alkaloid-free petasites |
| 08/10/2006 | WO2006083434A1 Use of arachidonic acid and its derivatives for increasing skeletal muscle mass |
| 08/10/2006 | WO2006083183A1 Use of myostatin (gdf-8) antagonists for treatment of sarcopenia (age-related muscle-wasting) |
| 08/10/2006 | WO2006082952A1 Amide compound |
| 08/10/2006 | WO2003065999A3 Proliferated cell lines and uses thereof |
| 08/10/2006 | US20060178516 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
| 08/10/2006 | US20060178401 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 08/10/2006 | US20060178375 2-(1-Cyclopentylpiperidin-4-yloxy)-5-(4-cyanophenyl)pyrimidine, for example; exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful for the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep disorders |
| 08/10/2006 | US20060178372 Therapeutic quinoline compounds |
| 08/10/2006 | US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents |
| 08/10/2006 | US20060178336 Oral administration of therapeutic agent coupled to transporting agent induces tolerance |
| 08/10/2006 | US20060178333 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof |
| 08/10/2006 | US20060178315 For therapy of immune or autoimmune diseases |
| 08/10/2006 | US20060177432 Methods and reagents for protease inhibition |
| 08/10/2006 | US20060177382 Delivery of antiemetics through an inhalation route |
| 08/10/2006 | CA2597152A1 Use of myostatin (gdf-8) antagonists for treatment of sarcopenia (age-related muscle-wasting) |
| 08/09/2006 | EP1687277A1 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 08/09/2006 | EP1453949B1 Production of cell suspensions |
| 08/09/2006 | EP1453832B1 Ring fused pyrazole derivatives |
| 08/09/2006 | EP1383483A4 Controlled delivery of tetracycline compounds and tetracycline derivatives |
| 08/09/2006 | EP1032393B1 Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 08/09/2006 | CN1816353A Medicinal composition for preventing or treating Th1 type immunological disease |
| 08/09/2006 | CN1268753C Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/09/2006 | CN1268744C Novel neurotrophic factors |
| 08/09/2006 | CN1268625C Cyclic amp-specific phosphodiesterase inhibitors |
| 08/09/2006 | CN1268394C Binding domain-immunoglobulin fusion proteins |
| 08/09/2006 | CN1268234C Method and compositions for increasing anaerobic working capacity in tissues |
| 08/08/2006 | US7087759 for controlling weight; pyrrolidine or piperidine compounds |
| 08/08/2006 | US7087647 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 08/08/2006 | US7087628 Heteroaryl and heterocyclic nitrogen ring containing hydrazide compounds useful for treating neurodegenerative disorderes |
| 08/08/2006 | US7087626 TGF-beta signal transduction inhibitors |
| 08/08/2006 | US7087624 Substituted pyrazole compounds |
| 08/08/2006 | US7087614 Pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087217 Condensation aerosol for delivery of a drug selected from the group consisting of indomethacin, ketoprofen, celcoxib, rofecoxib, meclofenamic acid, fenoprofen, diflunisal, tolfenamic acid, naproxen, ibuprofen, flurbiprofen and nabumetone |
| 08/08/2006 | US7087216 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone |
| 08/08/2006 | CA2356985C 5ht1 antagonists for antidepressant therapy |
| 08/03/2006 | WO2006080533A1 3-amino-1,2,4-triazole derivative |
| 08/03/2006 | WO2006079217A1 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis |
| 08/03/2006 | US20060173075 P-(sulfonyl) aryl and heteroarylamines-as anti-inflammatory agents |
| 08/03/2006 | US20060173045 Preventative or remedy for grinding |
| 08/03/2006 | US20060173010 Modulators of TNF-alpha signaling |
| 08/03/2006 | US20060173003 4-Heteroarylamino-7-H(hetero)aryl-substituted, e.g., [6-(propane-2-sulfonyl)-pyridin-3-yl]-[7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl ]-amine hydrochloride; the compounds inhibit binding of vanilloid ligands to capsaicin receptors and are used to treat neuropathic pain |
| 08/03/2006 | US20060171928 Monocyte-origin multipotent cell momc |
| 08/03/2006 | US20060171881 Compounds with high monoamine transporter affinity |
| 08/03/2006 | CA2595942A1 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis |
| 08/02/2006 | EP1686175A2 Proteins and nucleic acids encoding same |
| 08/02/2006 | EP1686130A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 08/02/2006 | EP1478380B1 Use of tyrosine kinase inhibitors for treating cns disorders |
| 08/02/2006 | EP1395242B1 Liquid pharmaceutical composition |
| 08/02/2006 | EP1272196B1 Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha,11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |
| 08/02/2006 | EP1267828B1 Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients |
| 08/02/2006 | EP1212328B1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 08/02/2006 | CN1812981A Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 08/02/2006 | CN1267408C Compound, compositions and methods for preventing neurodegeneration in acute and chronic injuries in central nervous system |
| 08/02/2006 | CN1267407C Prodrugs of excitatory amino acids |
| 08/02/2006 | CN1267099C Medicament with protective effect against oxidative-toxic substances, particularly against cardiotoxin substances |
| 08/01/2006 | US7084159 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 08/01/2006 | US7084156 2-Aminoquinoline compounds |
| 08/01/2006 | US7084143 N-(indolecarbonyl) piperazine derivatives |
| 08/01/2006 | CA2338214C Heterocyclic compounds as inhibitors of rotamase enzymes |
| 07/27/2006 | WO2006078056A1 Drugs for activating muscle satellite cell |
| 07/27/2006 | US20060168672 B7-like molecules and uses thereof |
| 07/27/2006 | US20060167251 CCR9 inhibitors and methods of use thereof |
| 07/27/2006 | US20060167086 Medicinal composition |
| 07/27/2006 | US20060167048 N-4-piperidinyl compounds as ccr5 modulators |
| 07/27/2006 | US20060167002 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists |
| 07/27/2006 | US20060166978 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 07/27/2006 | US20060166940 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases |
| 07/27/2006 | US20060165757 5-hydroxysapogenin derivatives with anti-dementia activity |
| 07/27/2006 | US20060165733 Liquid formulations with high concentration of hunan growth hormone (hgh) comprising phenol |
| 07/27/2006 | US20060165721 Cinnamomi and poria composition, method to prepare same and uses thereof |
| 07/27/2006 | US20060165672 Fatigue reducing agent |
| 07/26/2006 | EP1682137A1 Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pain |
| 07/26/2006 | EP1513839B1 3-substituted quinuclidines and their use |
| 07/26/2006 | EP1465921B1 Corticotropin releasing factor receptor 2 agonists |
| 07/26/2006 | EP1414447B1 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 07/26/2006 | EP1381686B1 Inactivation of genes of the mep pathway |
| 07/26/2006 | EP1357906B1 Blockade of sodium channels by phenol derivatives |
| 07/26/2006 | EP1242067B1 Calcium formate as a dietary supplement |
| 07/26/2006 | CN1809570A [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 07/26/2006 | CN1809365A Use of adenosine receptor agonists in therapy |
| 07/26/2006 | CN1266126C Phenethanolamine derivatives for treatment of respiratory diseases |
| 07/25/2006 | US7081476 Tocopherol enriched compositions for reducing IL6 levels |
| 07/25/2006 | US7081239 Administering formulation comprising peptide YY or antagonists of receptors for peptide YY for manipulating the rate of upper gastrointestinal transit of a substance in a mammal having an intrinsic cholinergic afferent neural pathway |
| 07/20/2006 | WO2006053872A8 The use of anti-oxidant compounds for muscle recovery |
| 07/19/2006 | EP1681355A1 Sequence-specific DNA recombination in eukaryotic cells |
| 07/19/2006 | EP1164991A4 Gels formed by the interaction of poly(aldehyde) with various substances |
| 07/19/2006 | CN1264821C Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 07/18/2006 | US7078515 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalized epilepsy with febrile seizures plus |
| 07/18/2006 | US7078410 4-substituted with a imidazo[1,2a]pyrid-3-yl or pyrazolo[2,3a]pyrid-3-yl ring |
| 07/18/2006 | US7078405 Psychological disorders; anxiolytic agents; dietetics; autoimmune diseases; antidepressants |
| 07/18/2006 | US7078403 Antiviral agents |
| 07/18/2006 | US7078173 Assays and therapies for latent viral infection |
| 07/18/2006 | US7078052 Enhanced absorption and bioavailability |